Editorial (New Wave from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistr )

It is my great honor to introduce new wind from Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (IEMAMC) as an exciting forum for exchanging thoughts and experiences about basic and clinical research to solve the problems in Immunology, Endocrine & Metabolism. IEMAMC aims to cover all the latest and outstanding developments in the medicinal chemistry and rational drug design for the discovery of new immunology, endocrine & metabolic agents. This area is now rapidly growing due to the tremendous increase in the population of the diabetes and obesity. Each issue contains a series of timely in-depth reviews and original research articles written by leaders in the field covering a range of current topics in immunology, endocrine & metabolic medicinal chemistry. In this age, IEMAMC would offer new cutting edge in this field. The aim of IEMAMC is to report rapidly new theories, methods and techniques for prevention, diagnosis, and treatment in the field of immunology, endocrinology and metabolism. IEMAMC covers the topics concerning diabetes, atherosclerosis, obesity, endocrinology, hypertension, cardiovascular and cerebrovascular diseases, clinical aspects and trials for diabetes, hypertension, endocrine, metabolic disorders, and others. The mission of IEMAMC is to foster excellence in immunology, endocrinology and metabolism research, for the prevention of cardiovascular diseases and stroke. If you have not yet submitted to IEMAMC, now is the time to join. Together with the excellent Editorial Board Members, I look forward to serving the readers of IEMAMC and to working with you over the next few years so that the objectives of the missions of IEMAMC will be successfully achieved. So, if you want to share any new idea, any basic research, any clinical experiences in immunology, endocrinology and metabolism, IEMAMC is happy to provide a space to you!